Titratable fixed‐ratio combination of basal insulin plus a glucagon‐like peptide‐1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes-Reference-Cited by-同舟云学术

Titratable fixed‐ratio combination of basal insulin plus a glucagon‐like peptide‐1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes

Published:2021-03-31 Issue:7 Volume:23 Page:1445-1452
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Gomez‐Peralta Fernando¹^ORCID,Al‐Ozairi Ebaa²,Jude Edward B.³⁴^ORCID,Li Xiaoying⁵,Rosenstock Julio⁶^ORCID

Affiliation:

1. Endocrinology and Nutrition Unit Segovia General Hospital Segovia Spain

2. Dasman Diabetes Institute Kuwait City Kuwait

3. Tameside and Glossop Integrated Care NHS Foundation Trust Ashton‐under‐Lyne UK

4. University of Manchester Manchester UK

5. Department of Endocrinology, Zhongshan Hospital Fudan University Shanghai China

6. Dallas Diabetes Research Center at Medical City Dallas Texas USA

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14365

Reference59 articles.

1. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

2. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

3. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021

5. National Institute for Clinical Excellence (NICE). Type 2 diabetes in adults: management. 2015.https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493. Accessed 30 June 2020.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-intensification as a new trend in the treatment of type 2;FOCUS. Endocrinology;2024-05-13

2. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

3. The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review;Diabetes Therapy;2024-04-04

4. Current barriers to initiating insulin therapy in individuals with type 2 diabetes;Frontiers in Endocrinology;2024-03-14

5. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30